For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Post-diagnosis risk assessment clarifies cancer etiology and germline contribution, shaping therapeutic planning, prevention ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

Cancer risk assessed by genome sequencing may give misleadingly high estimates if family history is not taken into account, according to a new study from the University of Exeter. The researchers ...